363 related articles for article (PubMed ID: 37673862)
1. Immune landscape and redox imbalance during neurological disorders in COVID-19.
Thakur A; Sharma V; Averbek S; Liang L; Pandya N; Kumar G; Cili A; Zhang K
Cell Death Dis; 2023 Sep; 14(9):593. PubMed ID: 37673862
[TBL] [Abstract][Full Text] [Related]
2. Neurological manifestations of SARS-CoV-2: complexity, mechanism and associated disorders.
Tyagi K; Rai P; Gautam A; Kaur H; Kapoor S; Suttee A; Jaiswal PK; Sharma A; Singh G; Barnwal RP
Eur J Med Res; 2023 Aug; 28(1):307. PubMed ID: 37649125
[TBL] [Abstract][Full Text] [Related]
3. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
Jha NK; Ojha S; Jha SK; Dureja H; Singh SK; Shukla SD; Chellappan DK; Gupta G; Bhardwaj S; Kumar N; Jeyaraman M; Jain R; Muthu S; Kar R; Kumar D; Goswami VK; Ruokolainen J; Kesari KK; Singh SK; Dua K
J Mol Neurosci; 2021 Nov; 71(11):2192-2209. PubMed ID: 33464535
[TBL] [Abstract][Full Text] [Related]
4. Possible mechanism of central nervous system targeting and neurological symptoms of the new-coronavirus (COVID-19): literature review.
Jumagaliyeva M; Ayaganov D; Saparbayev S; Tuychibaeva N; Abdelazim IA; Kurmambayev Y; Khamidullina Z; Yessenamanova S
Eur Rev Med Pharmacol Sci; 2023 Oct; 27(19):9420-9428. PubMed ID: 37843354
[TBL] [Abstract][Full Text] [Related]
5. Cytokine storm induced by SARS-CoV-2 infection: The spectrum of its neurological manifestations.
Thepmankorn P; Bach J; Lasfar A; Zhao X; Souayah S; Chong ZZ; Souayah N
Cytokine; 2021 Feb; 138():155404. PubMed ID: 33360025
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Induced Neurological Manifestations Entangles Cytokine Storm that Implicates for Therapeutic Strategies.
Chong ZZ; Souayah N
Curr Med Chem; 2022; 29(12):2051-2074. PubMed ID: 33970839
[TBL] [Abstract][Full Text] [Related]
7. Severe Acute Respiratory Syndrome Coronavirus 2 Impact on the Central Nervous System: Are Astrocytes and Microglia Main Players or Merely Bystanders?
Murta V; Villarreal A; Ramos AJ
ASN Neuro; 2020; 12():1759091420954960. PubMed ID: 32878468
[TBL] [Abstract][Full Text] [Related]
8. The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies.
Zalpoor H; Akbari A; Samei A; Forghaniesfidvajani R; Kamali M; Afzalnia A; Manshouri S; Heidari F; Pornour M; Khoshmirsafa M; Aazami H; Seif F
Cell Mol Biol Lett; 2022 Feb; 27(1):10. PubMed ID: 35109786
[TBL] [Abstract][Full Text] [Related]
9. Crosstalk between SARS-CoV-2 Infection and Neurological Disorders: A Review.
Azhar A; Wali MA; Rashid Q; Khan WH; Al-Hosaini K; Owais M; Kamal MA
CNS Neurol Disord Drug Targets; 2023; 22(5):643-658. PubMed ID: 35440321
[TBL] [Abstract][Full Text] [Related]
10. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.
Yachou Y; El Idrissi A; Belapasov V; Ait Benali S
Neurol Sci; 2020 Oct; 41(10):2657-2669. PubMed ID: 32725449
[TBL] [Abstract][Full Text] [Related]
11. Neuro-COVID-19: an insidious virus in action.
Bratosiewicz-Wąsik J
Neurol Neurochir Pol; 2022; 56(1):48-60. PubMed ID: 34642927
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 mediated neurological disorders in COVID-19: Measuring the pathophysiology and immune response.
Hsu PC; Shahed-Al-Mahmud M
Life Sci; 2022 Nov; 308():120981. PubMed ID: 36150465
[TBL] [Abstract][Full Text] [Related]
13. Potential mechanism of SARS-CoV-2-associated central and peripheral nervous system impairment.
Zhang Y; Chen X; Jia L; Zhang Y
Acta Neurol Scand; 2022 Sep; 146(3):225-236. PubMed ID: 35699161
[TBL] [Abstract][Full Text] [Related]
14. Severe acute respiratory syndrome coronavirus 2 invasion in the central nervous system: a host-virus deadlock.
Baral PK; Nuruzzaman M; Uddin MS; Ferdous M; Chowdhury IH; Smrity SZ
Acta Virol; 2021; 65(2):115-126. PubMed ID: 34130463
[TBL] [Abstract][Full Text] [Related]
15. Neurological Implications of COVID-19: Role of Redox Imbalance and Mitochondrial Dysfunction.
Kaundal RK; Kalvala AK; Kumar A
Mol Neurobiol; 2021 Sep; 58(9):4575-4587. PubMed ID: 34110602
[TBL] [Abstract][Full Text] [Related]
16. An overview of the neurological aspects in COVID-19 infection.
Singh D; Singh E
J Chem Neuroanat; 2022 Jul; 122():102101. PubMed ID: 35430271
[TBL] [Abstract][Full Text] [Related]
17. Update on neurological manifestations of COVID-19.
Yavarpour-Bali H; Ghasemi-Kasman M
Life Sci; 2020 Sep; 257():118063. PubMed ID: 32652139
[TBL] [Abstract][Full Text] [Related]
18. Review of Neurological Manifestations of SARS-CoV-2.
Priyal ; Sehgal V; Kapila S; Taneja R; Mehmi P; Gulati N
Cureus; 2023 Apr; 15(4):e38194. PubMed ID: 37257164
[TBL] [Abstract][Full Text] [Related]
19. Replication Kinetics, Cell Tropism, and Associated Immune Responses in SARS-CoV-2- and H5N1 Virus-Infected Human Induced Pluripotent Stem Cell-Derived Neural Models.
Bauer L; Lendemeijer B; Leijten L; Embregts CWE; Rockx B; Kushner SA; de Vrij FMS; van Riel D
mSphere; 2021 Jun; 6(3):e0027021. PubMed ID: 34160239
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2: its potential neurological manifestations and plausible mechanism: a review article.
Taher T; Sheikh AB; Anwar F; Khosa F
Acta Neurol Belg; 2021 Apr; 121(2):331-339. PubMed ID: 33464546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
